GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Respiratory illnesses like the flu and COVID-19 spread more commonly in the fall and winter months ahead, and doctors in ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

Dr. Kerry-Anne Perkins, a new mom and board-certified OB-GYN shares what parents need to know about RSV and more.

Besides the flu, other respiratory viruses such as respiratory syncytial virus (RSV) and COVID also tend to peak during the ...

About 2.1% of antibiotic prescriptions over the study period were connected to RSV diagnoses, especially in seniors and ...

Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial ...

Pats breathe in Drake Maye’s 11.82 breathtaking seconds, let out ‘dumb decision’ in OT ‘I was a plumber – now at 34, I’ve ...